Subscribe
Israel-Hamas Conflict
NFL
Floods
Donald Trump
Volleyball
US Immigration
US Politics
Kamala Harris
Soccer
US Economy
San Francisco 49ers
Eric Adams
JD Vance
Published

Competition explodes amid weight loss drug shortage

Summary by The Hill
The rise of compounded GLP-1 medications is raising questions as competition heats up between established drug makers and telehealth companies.

0 Articles

All
Left
Center
Right
CNBCCNBC

Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says

The results suggest Ozempic could potentially become a new alternative treatment for opioid use disorder, which could help address the ongoing opioid epidemic.

·United States
Read Full Article
The HillThe Hill

Competition explodes amid weight loss drug shortage

The rise of compounded GLP-1 medications is raising questions as competition heats up between established drug makers and telehealth companies.

·Washington, United States
Read Full Article
BenzingaBenzinga

Popular Ozempic May Have New Use As Semaglutide Drugs Linked To Reduced Overdose Risk In Diabetic Opioid Users - Novo Nordisk (NYSE:NVO)

A study compared the association of semaglutide vs other antidiabetic medications and other GLP-1RAs, including liraglutide and dulaglutide, with opioid overdose risk in patients with comorbid type 2 diabetes (T2D) and opioid use disorder (OUD). Novo Nordisk A/S’ (NYSE:NVO) semaglutide is available as Wegovy and Ozempic for weight loss and diabetes, respectively, and liraglutide is sold as Saxenda and Victoza. Also Read: EXCLUSIVE: Novo Nordisk …

·New York, United States
Read Full Article
Washington ExaminerWashington Examiner

Ozempic could lower the risk of opioid overdoses, says new study

The breakthrough diabetes drug Ozempic may lower the risk of opioid overdoses in certain patients, according to a new study published Wednesday, signaling that the wonder drug may eventually be used as an alternative form of treatment for opioid use disorder. Semaglutide, the active ingredient in Ozempic and the weight loss drug Wegovy, was associated... The post Ozempic could lower the risk of opioid overdoses, says new study appeared first on …

·Washington, United States
Read Full Article
News MedicalNews Medical

Study links semaglutide to reduced opioid overdose risk in patients with OUD and diabetes

Since being deemed a public health emergency in 2017, opioids are responsible for 72% of drug overdose deaths in the United States, according to the National Center for Drug Abuse Statistics.

·United States
Read Full Article
Science DailyScience Daily

Popular diabetes and weight-loss drug associated with lower opioid overdose risk, study finds

Researchers have identified a potential new approach to address the opioid overdose epidemic. Semaglutide was shown to lower opioid overdoses in people with opioid-use disorder and type 2 diabetes.

·United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 94% of the sources are Center
94% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

DiabetesDiabetes
WegovyWegovy
Novo NordiskNovo Nordisk
OpioidsOpioids
HealthHealth
OzempicOzempic
FentanylFentanyl
Trending Topics
Ground News logo
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal